Karen Wain

Ms. Karen Wain

Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 October 2018 in Human Mutation
Verified
Journal Article
Closed access
PDF file
JSJuliann M. Savatt
Juliann M. Savatt
DADanielle R. Azzariti
Danielle R. Azzariti
WFW. Andrew Faucett
W. Andrew Faucett
SHSteven Harrison
Steven Harrison
JHJennifer Hart
Jennifer Hart
CMChrista Lese Martin
Christa Lese Martin

Verified
Journal Article
Open access
PDF file
KOKelly Ormond
Kelly Ormond
MBMaia J. Borensztein
Maia J. Borensztein
MHMiranda L. G. Hallquist
Miranda L. G. Hallquist
Adam H BuchananAdam H Buchanan
Adam H Buchanan
WFWilliam Andrew Faucett
William Andrew Faucett
OWOn Behalf Of The Clinical Genome Cadre Workgroup
On Behalf Of The Clinical Genome Cadre Workgroup
Purpose: Informed consent for genetic testing has historically been acquired during pretest genetic counseling, without specific guidance defining which core concepts are required. Methods: The Clinical Genome Resource (ClinGen) Consent and Disclosure Recommendations Workgroup (CADRe) used an expert consensus process to identify the core concepts essential to consent for clinical genetic testing. A literature review identified 77 concepts that are included in informed consent for genetic tests. Twenty-five experts (9 medical geneticists, 8 genetic counselors, and 9 bioethicists) completed two rounds of surveys ranking concepts’ importance to informed consent. Results: The most highly ranked concepts included: (1) genetic testing is voluntary; (2) why is the test recommended and what does it test for?; (3) what results will be returned and to whom?; (4) are there other types of potential results, and what choices exist?; (5) how will the prognosis and management be impacted by results?; (6) what is the potential family impact?; (7) what are the test limitations and next steps?; and (8) potential risk of genetic discrimination and legal protections. Conclusion: Defining the core concepts necessary for informed consent for genetic testing provides a foundation for quality patient care across a variety of healthcare providers and clinical indications.

1 April 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
KWKaren Wain
Karen Wain
DADanielle R. Azzariti
Danielle R. Azzariti
JGJennifer L. Goldstein
Jennifer L. Goldstein
AJAmy Knight Johnson
Amy Knight Johnson
PKPatti Krautscheid
Patti Krautscheid
CMChrista Lese Martin
Christa Lese Martin

11 October 2018 in Human Mutation
Verified
Journal Article
Closed access
PDF file
KWKaren Wain
Karen Wain
EPEmily Palen
Emily Palen
JSJuliann M. Savatt
Juliann M. Savatt
DSDevin Shuman
Devin Shuman
BFBrenda Finucane
Brenda Finucane
CMChrista Lese Martin
Christa Lese Martin

14 December 2023 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
JSJeffrey SoRelle
Jeffrey SoRelle
BFBirgit H. Funke
Birgit H. Funke
CECeleste Eno
Celeste Eno
JJJianling Ji
Jianling Ji
ASAvni Santani
Avni Santani
RMRong Mao
Rong Mao